Wilhelmus Kwanten

10PUBLICATIONS
27CO-AUTHORS
Molecular targetsMetabolic medicineCardiology (incl. cardiovascular diseases)Medical biochemistry - lipidsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Oct 08, 2026
Targeting Tumor-derived Sphingosine Kinase 2 Unleashes Antitumor Immunity and Improves Survival of Mice with Group 3 Medulloblastoma.

|Feb 25, 2025
MASH to cirrhosis: bridging the gaps in MASLD management.

Zouhir Gadi, Wilhelmus J Kwanten, Luisa Vonghia

|Jul 26, 2024
Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver disease.

Cédric Peleman, Stig Hellemans, Geraldine Veeckmans

|Mar 19, 2024
Spleen Stiffness-Based Algorithms Are Superior to Baveno VI Criteria to Rule Out Varices Needing Treatment in Patients With Advanced Chronic Liver Disease.

Emma Vanderschueren, Angelo Armandi, Wilhelmus Kwanten

|Nov 25, 2020
Author Correction: Non-invasive monitoring of chronic liver disease via near-infrared and shortwave-infrared imaging of endogenous lipofuscin.

Mari Saif, Wilhelmus J Kwanten, Jessica A Carr

|Jun 24, 2020
Non-invasive monitoring of chronic liver disease via near-infrared and shortwave-infrared imaging of endogenous lipofuscin.

Mari Saif, Wilhelmus J Kwanten, Jessica A Carr

Pageof 2

Frequent Collaborators

3 joint publications

Sven M Francque

2 joint publications

Rakesh K Jain

2 joint publications

Moungi G Bawendi

1 joint publications

Zouhir Gadi